Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

3.23
Delayed Data
As of 3:59pm ET
 +0.04 / +1.25%
Today’s Change
1.41
Today|||52-Week Range
3.65
+4.87%
Year-to-Date
Benzinga's Option Alert Recap From March 21
Mar 21 / Benzinga - Paid Partner Content
 

Today’s Trading

Previous close3.19
Today’s open3.15
Day’s range3.14 - 3.26
Volume977,055
Average volume (3 months)1,688,013
Market cap$867.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+50.85%
Earnings growth (this year)+42.11%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+58.31%
P/E ratioNM
Price/Sales5.05
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MEDPMedpace Holdings Inc+0.32+1.19%
AMRIAlbany Molecular Res...+0.25+1.89%
RGNXRegenxbio Inc+0.20+0.99%
BSTCBiospecifics Technol...+1.25+2.46%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 12, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$129.2M
Annual profit (last year)-$85.8M
Net profit margin-66.38%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs